The controversy surrounding a new emergency contraceptive — ulipristal acetate, also known as “ella” — that is shown to prevent pregnancy for up to five days after unprotected sex could raise some “politically charged questions” when an FDA panel considers approving the drug this week, the Washington Post reports…
Related posts:
on
No Comments on “FDA Panel Considering Approval Of New Emergency Contraceptive Pill”
You can track this conversation through its atom feed.